Showing Results for: “diabetes exercise”

New study points to diabetes management as critical factor in improving patient outcomes during pandemic outbreaks Findings of a new study show diabetes was the main risk factor for the accelerated advancement to a severe state in Japanese COVID-19 patients. Results of the retrospective analysis were presented at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Throughout the pandemic, diabetes has persisted as a significant risk factor for COVID-19. In hospitalized patients with diabetes and COVID-19, one in 10 people die within seven days of admission

The American Diabetes Association® (ADA) is pleased to announce Emmy Award winning journalist, Michelle Marsh of ABC7 as the honorary chair for this year's Virtual Step Out DC. The event is taking place on Saturday, September 26, 2020. The ADA encourages everyone to walk 3.4 miles in support of the 34 million Americans living with diabetes. It is more important than ever to raise awareness around the diabetes epidemic that is ravishing our communities. We will celebrate and honor those thriving with diabetes while helping to propel the mission of the ADA. “I’m thrilled to be serving as the

The American Diabetes Association® applauds New Hampshire’s governor and legislature for passing a cap on insulin co-pays Today, New Hampshire House Bill 1280 was signed into law by Governor Chris Sununu. A provision in the law limits cost sharing for insulin to $30 per 30-day supply for those with state-regulated commercial health insurance, a measure supported by the American Diabetes Association (ADA). The new law will take effect on September 14, 2020. Stephen Habbe, Director for State Government Affairs for the ADA, issued the following statement: “One of the most urgent issues faced by

NIDDK study continues to look at possible factors that lead to the development of the diseases in children New results and information surrounding potential “triggers” of the autoimmune process leading to type 1 diabetes (T1D) and how they interact with genetic factors in children at-risk for developing the disease were highlighted in the “Update from the TEDDY Study” symposium today at the American Diabetes Association’s® (ADA’s) 80th Virtual Scientific Sessions. Similar evidence for celiac disease is also being accumulated through the large international study program. The data The

Insulin Price Reduction Act, Safe Step Act, and Chronic Condition Copay Elimination Act are first bills analyzed and supported by ADA’s newly launched Advocacy Engagement Platform The American Diabetes Association (ADA) announced formal endorsement of three bills aiming to reduce the high cost of insulin and prescription drugs: the Insulin Price Reduction Act, the Safe Step Act, and the Chronic Condition Copay Elimination Act. The three bills were analyzed using ADA’s newly launched Engagement Platform . The Insulin Price Reduction Act (H.R.4906/S.2199) will reduce the skyrocketing cost of

Study presented at ADA’s Scientific Sessions compared insulin-only mode of iLet to usual care The iLet bionic pancreas (BP)¹ significantly increased the percentage of time adults with type 1 diabetes (T1D) had glucose levels between 70–180 mg/dl, when compared to usual care (UC) therapy of either multiple daily insulin injections (MDI) or continuous subcutaneous insulin infusion (CSII), according to the study, “First Human Study Testing the iLet, a Purpose-Built Bionic Pancreas Platform,” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone

Noviembre es el Mes de Conciencia sobre la Diabetes®, un momento en el que la Asociación Americana de la Diabetes® (ADA) y el mundo se unen para luchar contra la diabetes. A nivel nacional, más de 38 millones de personas tienen diabetes y casi 98 millones tienen prediabetes. En los últimos 20 años, el número de estadounidenses con diagnóstico de diabetes se ha más que duplicado. Para muchos, un diagnóstico de diabetes trae consigo un impacto emocional y preocupaciones sobre los costos, el cuidado y cómo cambiará su vida. La ADA está aquí con recursos para apoyar a las personas donde estén

Eager to repeat the successes of last year's partnership, GNC, the global leader in health and wellness, and the American Diabetes Association ® (ADA) have once again teamed up to launch a national fundraising campaign aimed to support the over 38 million Americans living with diabetes and the millions more at risk. GNC customers can now participate by making donations at their local GNC store or online, with options to round up their purchase to the nearest dollar or select a donation amount of their choice. All proceeds will directly benefit the ADA, supporting their crucial work in diabetes

New York has eliminated cost-sharing for insulin in state-regulated health plans. In response Monica Billger, state government affairs director at the American Diabetes Association ® (ADA), issued the following statement. “The American Diabetes Association is excited to celebrate a first in our nation. New York has taken a transformative step in the state budget to address medication affordability and accessibility by eliminating cost-sharing for insulin in state-regulated health plans. The ADA, in partnership with an amazing community of Diabetes Advocates, has long-led the fight to make